Supriya Lifescience - Quaterly Results

07 Nov 2023 Evaluate
The company witnessed a 24.89% growth in the revenue at Rs. 1400.95 millions for the quarter ended September 2023 as compared to Rs. 1121.72 millions during the year-ago period.A good growth in profit of 41.64% reported to Rs. 238.84  millions over Rs. 168.62 millions of corresponding previous quarter.The company reported a good operating profit of 342.19 millions compared to 311.67 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 1400.95 1121.72 24.89 2721.16 2135.27 27.44 4609.38 5300.49 -13.04
Other Income 24.67 26.05 -5.30 53.85 49.62 8.52 94.89 75.77 25.23
PBIDT 342.19 311.67 9.79 816.28 647.70 26.03 1383.87 2215.62 -37.54
Interest 4.60 7.75 -40.65 12.76 13.56 -5.90 30.84 41.98 -26.54
PBDT 337.59 303.92 11.08 803.52 634.14 26.71 1353.03 2173.64 -37.75
Depreciation 39.81 29.73 33.91 79.36 58.58 35.47 118.15 101.18 16.77
PBT 297.78 274.19 8.60 724.16 575.56 25.82 1234.88 2072.46 -40.41
TAX 58.94 105.57 -44.17 200.20 154.44 29.63 336.30 554.35 -39.33
Deferred Tax -26.44 0.91 -3005.49 15.19 3.91 288.49 29.49 32.46 -9.15
PAT 238.84 168.62 41.64 523.96 421.12 24.42 898.58 1518.11 -40.81
Equity 160.97 160.97 0.00 160.97 160.97 0.00 160.97 160.97 0.00
PBIDTM(%) 24.43 27.79 -12.09 30.00 30.33 -1.11 30.02 41.80 -28.18

Supriya Lifescience Share Price

745.85 0.95 (0.13%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×